共 50 条
- [31] The role of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer - The Khayat et al article reviewed ONCOLOGY-NEW YORK, 2001, 15 (04): : 430 - +
- [32] Follicular lymphoma: Expanding therapeutic options - The Ganti/Bociek/Bierman et al article reviewed ONCOLOGY-NEW YORK, 2005, 19 (02): : 234 - 235
- [33] Transplant registries: Guiding clinical decisions and improving outcomes - The Horowitz et al article reviewed ONCOLOGY-NEW YORK, 2001, 15 (05): : 666 - 666
- [34] Lessons Learned From the Use of ESAs The Bennett/McKoy/Henke et al article reviewed ONCOLOGY-NEW YORK, 2010, 24 (03): : 275 - 279
- [35] The moving target of cancer care costs - The McKoy/Fitzner/Edwards et al article reviewed ONCOLOGY-NEW YORK, 2007, 21 (07): : 862 - +
- [36] A new era in the management of multiple myeloma - The Ghobrial/Ghobrial/Mitsiades et al article reviewed ONCOLOGY-NEW YORK, 2007, 21 (07): : 800 - 800
- [37] Erlotinib in pancreatic cancer: A major breakthrough? The Senderowicz/Johnson/Sridhara et al article reviewed ONCOLOGY-NEW YORK, 2007, 21 (14): : 1706 - +
- [38] On the Road to Intraoperative Radiotherapy: More 'Proceed With Caution' Signs THE ASH ET AL ARTICLE REVIEWED ONCOLOGY-NEW YORK, 2013, 27 (02): : 113 - +
- [39] Neoadjuvant chemotherapy for ovarian cancer - The Vergote/Van Gorp/Amant et al article reviewed ONCOLOGY-NEW YORK, 2005, 19 (12): : 1628 - +
- [40] Proton Therapy for Prostate Cancer: Show Me the CER! THE HOPPE ET AL ARTICLE REVIEWED ONCOLOGY-NEW YORK, 2011, 25 (07): : 652 - 657